Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomaterial Delivery Systems for mRNA Vaccines
Michael D. Buschmann, Manuel Carrasco, Suman Alishetty, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 65-65
Open Access | Times Cited: 446

Showing 26-50 of 446 citing articles:

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Pardis Kazemian, Si-Yue Yu, Sarah B. Thomson, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 6, pp. 1669-1686
Open Access | Times Cited: 142
Delivery Strategies for mRNA Vaccines
Sivakumar Ramachandran, Soumya Ranjan Satapathy, Tathagata Dutta
Pharmaceutical Medicine (2022) Vol. 36, Iss. 1, pp. 11-20
Open Access | Times Cited: 125
Nanomaterials Synthesis through Microfluidic Methods: An Updated Overview
Adelina-Gabriela Niculescu, Cristina Chircov, Alexandra Cătălina Bîrcă, et al.
Nanomaterials (2021) Vol. 11, Iss. 4, pp. 864-864
Open Access | Times Cited: 124
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert, et al.
EClinicalMedicine (2022) Vol. 44, pp. 101262-101262
Open Access | Times Cited: 116
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 113
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 104
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 103
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 101
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
Xuexiang Han, Mohamad‐Gabriel Alameh, Kamila Butowska, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 9, pp. 1105-1114
Open Access | Times Cited: 99
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines
Takashi Nakamura, Yusuke Sato, Yuma Yamada, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114417-114417
Open Access | Times Cited: 86
mRNA nanomedicine: Design and recent applications
Luke J. Kubiatowicz, Animesh Mohapatra, Nishta Krishnan, et al.
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 84
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
Xuexiang Han, Ningqiang Gong, Lulu Xue, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 84
Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines
Esperanza Padín-González, Pearl Lancaster, Massimo Bottini, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 71
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain
Koki Ogawa, Naoya Kato, Michiharu Yoshida, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 34-41
Open Access | Times Cited: 67
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 56
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 52
The emerging role of nanotechnology in plant genetic engineering
Henry Squire, Sophia Tomatz, Elizabeth Voke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 5, pp. 314-328
Closed Access | Times Cited: 52
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids
Monique Culturato Padilha Mendonça, Ayse Kont, Piotr S. Kowalski, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103505-103505
Open Access | Times Cited: 49

Scroll to top